Search Within

Jill M Vanak

Formats
  1. Meeting Abstract (8)
  2. Journal Article (6)
Groups
  1. Nursing (14)
  2. Center for Hematologic Malignancies (13)
  3. Department of Medicine (13)
  4. Hematologic Malignancies, Division of (13)
  5. Lymphoma (10)
  6. Survivorship Research (9)

More Groups

People
  1. Craig Moskowitz (9)
  2. Andrew Zelenetz (7)
  3. Alison Moskowitz (6)
  4. Jocelyn Migliacci (6)
  5. Joachim Yahalom (5)
  6. Ariela Noy (4)

More People

Years
  1. 2016 (3)
  2. 2013 (1)
  3. 2011 (1)
  4. 2010 (3)
  5. 2009 (4)
  6. 2008 (2)
Publications
  1. Blood (6)
  2. Biology of Blood and Marrow Transplantation (4)
  3. British Journal of Haematology (3)
  4. Bone Marrow Transplantation (1)
Publishers
  1. American Society of Hematology (6)
  2. Elsevier Inc. (4)
  3. John Wiley & Sons (3)
  4. Nature Publishing Group (1)

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: Efficacy and cost analysis study
    Journal Article

    Afifi, S.; Adel, N. G.; Devlin, S.; Duck, E.; Vanak, J.; Landau, H.; Chung, D. J.; Lendvai, N.; Lesokhin, A.; Korde, N.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Pilot trial of homebound stem cell transplantation at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Vanak, J. M.; Bello, C.; Dixit, P.; Nguyen, V.; Landau, H.; Giralt, S. A.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Progress towards value in healthcare: Implementation of Time-Driven Activity-Based Costing (TDABC) in hematopoietic stem cell transplantation
    Meeting Abstract

    Vanak, J. M.; Cheavers, C.; Duggan, E.; Duck, E.; Radzyner, M.; Nelson, P.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Establishing a post-hematopoietic stem cell transplant immunization clinic: A single institution experience
    Meeting Abstract

    Vanak, J. M.; Albano, M.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: Results from two transplant centres
    Journal Article

    Smith, S. D.; Moskowitz, C. H.; Dean, R.; Pohlman, B.; Sobecks, R.; Copelan, E.; Andresen, S.; Bolwell, B.; Maragulia, J. C.; Vanak, J. M.; more...
    British Journal of Haematology (2011)

    Fulltext@MSK | Save
  • High number of successful mobilizations associated with the use of plerixafor and colony stimulating factors in patients with multiple myeloma (MM) and lymphoma treated at Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Adel, N. G.; Mathew, S.; Harnicar, S. J.; Mccullagh, E.; Landau, H.; Giralt, S.; Vanak, J.; Chimento, D.; Lucarelli, C.; Matasar, M. J.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging: Research paper
    Journal Article

    Moskowitz, C. H.; Yahalom, J.; Zelenetz, A. D.; Zhang, Z.; Filippa, D.; Teruya-Feldstein, J.; Kewalramani, T.; Moskowitz, A. J.; Rice, R.; Maragulia, J.; more...
    British Journal of Haematology (2010)

    Fulltext@MSK | Save
  • Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Yahalom, J.; Kewalramani, T.; Maragulia, J. C.; Vanak, J. M.; Zelenetz, A. D.; Moskowitz, C. H.
    Blood (2010)

    Fulltext@MSK | Save
  • Initial remission duration of less than 1 year is no longer an adverse prognostic factor for patients with relapsed HL undergoing high dose therapy and autologous stem cell transplant: Results of a combined analysis from two large transplant centers
    Meeting Abstract

    Moskowitz, A. J.; Sweetenham, J.; Bolwell, B. J.; Maragulia, J. C.; Vanak, J. M.; Moskowitz, C. H.; Smith, S.
    Blood (2009)

    Fulltext@MSK | Save
  • Bendamustine is highly active in heavily pre-treated relapsed and refractory Hodgkin lymphoma and serves as a bridge to allogeneic stem cell transplant
    Meeting Abstract

    Moskowitz, A. J.; Hamlin, P. A.; Gerecitano, J.; Horwitz, S. M.; Matasar, M.; Meikle, J.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; more...
    Blood (2009)

    Fulltext@MSK | Save